VanEck Pharmaceutical ETF (NASDAQ:PPH) Shares Sold by Lansing Street Advisors

Lansing Street Advisors trimmed its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 32.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 5,978 shares of the company’s stock after selling 2,821 shares during the period. Lansing Street Advisors’ holdings in VanEck Pharmaceutical ETF were worth $516,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of PPH. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management raised its position in shares of VanEck Pharmaceutical ETF by 117.4% during the 4th quarter. Mivtachim The Workers Social Insurance Fund Ltd. Under Special Management now owns 200,000 shares of the company’s stock worth $17,256,000 after purchasing an additional 108,000 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of VanEck Pharmaceutical ETF by 51.3% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 248,473 shares of the company’s stock worth $23,565,000 after purchasing an additional 84,273 shares during the last quarter. Adamsbrown Wealth Consultants LLC raised its position in shares of VanEck Pharmaceutical ETF by 102.3% during the 4th quarter. Adamsbrown Wealth Consultants LLC now owns 149,631 shares of the company’s stock worth $12,910,000 after purchasing an additional 75,659 shares during the last quarter. Thrivent Financial for Lutherans raised its position in shares of VanEck Pharmaceutical ETF by 33.6% during the 3rd quarter. Thrivent Financial for Lutherans now owns 234,890 shares of the company’s stock worth $22,322,000 after purchasing an additional 59,025 shares during the last quarter. Finally, Blue Chip Partners LLC acquired a new position in shares of VanEck Pharmaceutical ETF during the 4th quarter worth approximately $2,139,000.

VanEck Pharmaceutical ETF Price Performance

Shares of VanEck Pharmaceutical ETF stock opened at $91.26 on Friday. VanEck Pharmaceutical ETF has a 1 year low of $84.48 and a 1 year high of $99.51. The company has a market capitalization of $569.46 million, a P/E ratio of 21.04 and a beta of 0.72. The business has a 50 day moving average price of $87.74 and a 200 day moving average price of $91.47.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were given a dividend of $0.411 per share. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date of this dividend was Friday, December 27th.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.